Anna M.D. Watson
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
-
- Regulation of Appetite and Obesity
Papers in
-
- Heart Rate Variability and Autonomic Control 8
- Renin-Angiotensin System Studies 6
- Cardiovascular Disease and Adiposity 5
- Surgery 13
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 8
- Co-authors
- Karin Jandeleit‐Dahm (21 shared papers)Mark E. Cooper (10 shared papers)Clive N. May (9 shared papers)Merlin C. Thomas (8 shared papers)Aino Soro‐Paavonen (5 shared papers)Philip Koh (3 shared papers)Melinda T. Coughlan (3 shared papers)Michael J. McKinley (2 shared papers)
- Journals
- Hypertension (6 papers)Diabetologia (6 papers)Diabetes (5 papers)Frontiers in Physiology (3 papers)American Journal of Physiology-Regulatory, Integrative and Comparative Physiology (3 papers)
- Partner nations
- AustraliaGermanyUnited States
In The Last Decade
Anna M.D. Watson
46 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 97
- Clinical Biochemistry 463
- Endocrine and Autonomic Systems 459
- Nephrology 222
- Endocrinology, Diabetes and Metabolism 419
- Cancer Research 378
Countries citing papers authored by Anna M.D. Watson
This map shows the geographic impact of Anna M.D. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M.D. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M.D. Watson more than expected).
Fields of papers citing papers by Anna M.D. Watson
This network shows the impact of papers produced by Anna M.D. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M.D. Watson. The network helps show where Anna M.D. Watson may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna M.D. Watson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 339 | |
| 2 | 2010 | 296 | |
| 3 | 2002 | 263 | |
| 4 | 2010 | 221 | |
| 5 | 2001 | 172 | |
| 6 | 2006 | 82 | |
| 7 | 2003 | 74 | |
| 8 | 2009 | 65 | |
| 9 | 2015 | 64 | |
| 10 | 2013 | 64 | |
| 11 | 2008 | 62 | |
| 12 | 2007 | 60 | |
| 13 | 2010 | 60 | |
| 14 | 2012 | 57 | |
| 15 | 2017 | 47 | |
| 16 | 2004 | 41 | |
| 17 | 2013 | 34 | |
| 18 | 2012 | 34 | |
| 19 | 2017 | 33 | |
| 20 | 2009 | 30 |
About Anna M.D. Watson
Anna M.D. Watson is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Clinical Biochemistry, Physiology and Endocrinology, Diabetes and Metabolism, having authored 48 papers that have together received 2.5k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (10 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (8 papers), Heart Rate Variability and Autonomic Control (8 papers), Renin-Angiotensin System Studies (6 papers), Apelin-related biomedical research (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Cardiovascular Disease and Adiposity (5 papers) and Chronic Kidney Disease and Diabetes (5 papers). The work is most often cited by research in Clinical Biochemistry (463 citations), Endocrine and Autonomic Systems (459 citations), Nephrology (222 citations), Endocrinology, Diabetes and Metabolism (419 citations) and Cancer Research (378 citations). Anna M.D. Watson has collaborated with scholars based in Australia, Germany and United States. Frequent co-authors include Karin Jandeleit‐Dahm, Mark E. Cooper, Clive N. May, Merlin C. Thomas, Aino Soro‐Paavonen, Philip Koh, Melinda T. Coughlan, Michael J. McKinley, Phillip Kantharidis and Wendy C. Burns. Their work appears in journals such as Hypertension, Diabetologia, Diabetes, Frontiers in Physiology and American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.